Drug:
Reaction: URINARY TRACT INFECTION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940158 |
US |
66 | 1 |
Myocardial infarction, Urinary tract infection, Cough, Lower respiratory tract infection, |
||||
RISANKIZUMAB-RZAA, |
||||
| 2 | 26940499 |
US |
51 | 2 |
Asthma, Urinary tract infection, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3 | 26940632 |
US |
2 | |
Urinary tract infection, Injection site haemorrhage, Injection site reaction, Palpitations, Headache, Nausea, |
||||
ABALOPARATIDE, |
||||
| 4 | 26940929 |
US |
2 | |
Urinary tract infection, Musculoskeletal discomfort, Rash pruritic, Balance disorder, Vertigo, Nausea, Diarrhoea, Constipation, Fatigue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 5 | 26940979 |
US |
2 | |
Urinary tract infection, Headache, Dizziness, Nausea, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 6 | 26941017 |
US |
2 | |
Peripheral artery surgery, Urinary tract infection, Contusion, |
||||
ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EZETIMIBE, MAGNESIUM, |
||||
| 7 | 26941309 |
US |
67 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 8 | 26941431 |
US |
73 | 2 |
Nephrolithiasis, Urinary tract infection, |
||||
LENALIDOMIDE, |
||||
| 9 | 26941596 |
US |
70 | 2 |
Feeling cold, Urinary tract infection, Nocturia, |
||||
ABALOPARATIDE, ABALOPARATIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, HYDROXYCHLOROQUINE SULFATE, URSODIOL, URSOSIOL, MYCOPHENOLIC ACID, |
||||
| 10 | 26941605 |
US |
61 | 2 |
Sinus headache, Urinary tract infection, Feeling abnormal, Dizziness, Fatigue, Palpitations, Product dose omission issue, Product administered at inappropriate site, |
||||
ABALOPARATIDE, ABALOPARATIDE, CARVEDILOL, CYANOCOBALAMIN, SPIRONOLACTONE, |
||||
| 11 | 26941700 |
US |
88 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 12 | 26941987 |
US |
2 | |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, EZETIMIBE, PANTOPRAZOLE, HYDROCHLOROTHIAZIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, OXYCODONE, GABAPENTIN, BUPROPION HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, NITROGLYCERIN, RIVASTIGMINE, |
||||
| 13 | 26942065 |
US |
74 | 1 |
Generalised tonic-clonic seizure, On and off phenomenon, Gait disturbance, Illness, Condition aggravated, Therapeutic response shortened, Urinary tract infection, Asthenia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 14 | 26942491 |
US |
45 | 2 |
Urinary tract infection, Upper respiratory tract infection, Headache, Arthralgia, Pyrexia, Protein urine present, Inflammatory marker increased, Blood immunoglobulin G increased, Blood immunoglobulin E increased, Serum ferritin increased, Anaemia, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, VEDOLIZUMAB, |
||||
| 15 | 26942551 |
US |
75 | 2 |
Pulmonary embolism, Urinary tract infection, COVID-19, |
||||
PIMAVANSERIN TARTRATE, EZETIMIBE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CARBIDOPA AND LEVODOPA, CYANOCOBALAMIN, PRAMIPEXOLE, LISINOPRIL, VITAMIN C, FUROSEMIDE, VIBEGRON, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CEFUROXIME, PANTOPRAZOLE, |
||||
| 16 | 26942892 |
JP |
10 | 1 |
Tonic convulsion, Oxygen saturation decreased, Generalised tonic-clonic seizure, Urinary tract infection, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, CLONAZEPAM, DANTROLENE SODIUM, MAGNESIUM OXIDE, PHENOBARBITAL, PHENYTOIN, TIZANIDINE, |
||||
| 17 | 26943426 |
22 | 1 | |
Urinary retention, Dysuria, Urinary tract infection, |
||||
VILOXAZINE HYDROCHLORIDE, ERGOCALCIFEROL, ESCITALOPRAM, BUPROPION, TESTOSTERONE CYPIONATE, |
||||
| 18 | 26943628 |
EU |
69 | 2 |
Urinary tract infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 19 | 26943772 |
EU |
4 | 2 |
Sepsis, Cardiac failure, Acute respiratory distress syndrome, BK virus infection, Urinary tract infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, FLUDARABINE PHOSPHATE, THIOTEPA, TREOSULFAN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, CYCLOSPORINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 20 | 26943862 |
US |
1 | |
Urinary tract infection, Dementia with Lewy bodies, Off label use, |
||||
PIMAVANSERIN TARTRATE, EZETIMIBE, FESOTERODINE FUMARATE, ROSUVASTATIN, DONEPEZIL HYDROCHLORIDE, |
||||
| 21 | 26943869 |
US |
82 | |
Urinary tract infection, |
||||
ESTRADIOL, |
||||
| 22 | 26943986 |
US |
54 | 2 |
Nephrolithiasis, Arthralgia, Arthralgia, Pain in extremity, Urinary tract infection, Fatigue, |
||||
UPADACITINIB, |
||||
| 23 | 26944026 |
US |
73 | 2 |
Psoriatic arthropathy, Alopecia, Oedema, Arthralgia, Urinary tract infection, Therapy interrupted, Psoriasis, Nail disorder, Otorrhoea, Dermatitis, Drug ineffective, Pruritus, Dry skin, Chills, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 24 | 26944460 |
US |
4 | 2 |
Urinary tract infection, Pneumonia, Oxygen saturation abnormal, Hospitalisation, Incorrect dose administered, |
||||
CANNABIDIOL, |
||||
| 25 | 26944646 |
US |
24 | 2 |
Seizure, Off label use, Urinary tract infection, Pain, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 26 | 26944717 |
US |
79 | 2 |
Urinary tract infection, Bone pain, Drug intolerance, Product administration error, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE, DONEPEZIL HYDROCHLORIDE, |
||||
| 27 | 26944737 |
US |
2 | |
Urinary tract infection, Vomiting projectile, Back pain, Diarrhoea, |
||||
ABALOPARATIDE, |
||||
| 28 | 26945018 |
US |
2 | |
Urinary tract infection, Hospice care, |
||||
ABALOPARATIDE, ABALOPARATIDE, CALCIUM, |
||||
| 29 | 26945040 |
US |
2 | |
Brain fog, Headache, Dizziness, Muscle spasms, Palpitations, Pruritus, Urinary tract infection, Respiratory symptom, Food craving, Weight increased, Product dose omission issue, |
||||
ABALOPARATIDE, FLUCONAZOLE, |
||||
| 30 | 26945068 |
US |
63 | |
Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 31 | 26945242 |
US |
2 | |
Myalgia, Dry skin, Urinary tract infection, Blood pressure increased, Dyspnoea, Vomiting, Palpitations, Bone pain, Nausea, Heart rate increased, Abdominal distension, Insomnia, Pruritus, Fatigue, Arthralgia, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHOCARBAMOL, FEXOFENADINE HYDROCHLORIDE, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, ERGOCALCIFEROL, CARVEDILOL, FISH OIL, CARVEDILOL, CARBOXYMETHYLCELLULOSE SODIUM, METHIMAZOLE, FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CALCIUM CARBONATE, ANTACID, PYRITHIONE ZINC, CETIRIZINE HYDROCHLORIDE, |
||||
| 32 | 26945257 |
US |
2 | |
Urinary tract infection, Micturition urgency, Bladder dilatation, Hypotension, Urinary tract infection, Intentional product misuse, |
||||
ABALOPARATIDE, |
||||
| 33 | 26945286 |
US |
2 | |
Urinary tract infection, Fall, Dizziness, Headache, Nausea, Back pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 34 | 26945308 |
US |
2 | |
Brain fog, Poor quality sleep, Urinary tract infection, Fatigue, Heart rate increased, Headache, Bone pain, |
||||
ABALOPARATIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 35 | 26945451 |
US |
2 | |
Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 36 | 26945537 |
US |
2 | |
Injection site hypertrophy, Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 37 | 26945632 |
US |
67 | 1 |
Nephrolithiasis, Urinary tract infection, |
||||
SPARSENTAN, |
||||
| 38 | 26945666 |
US |
||
Urinary tract infection, |
||||
OMALIZUMAB, |
||||
| 39 | 26946018 |
US |
64 | 2 |
Pneumonia, Urinary tract infection, |
||||
NATALIZUMAB, |
||||
| 40 | 26946037 |
US |
2 | |
Adverse drug reaction, Urinary tract infection, Abdominal pain upper, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 41 | 26946086 |
US |
2 | |
Urinary tract infection, |
||||
ABALOPARATIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, CALCIUM, CARVEDILOL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FUROSEMIDE, GABAPENTIN, METHOCARBAMOL, METHOCARBAMOL TABLETS, MIRABEGRON, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ROPINIROLE HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 42 | 26946310 |
US |
2 | |
Arthritis, Adverse event, Infection, Urinary tract infection, Blood test abnormal, Condition aggravated, Unevaluable event, Fatigue, Arthralgia, Pain in extremity, Product dose omission issue, |
||||
ABALOPARATIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PREDNISONE, |
||||
| 43 | 26946338 |
US |
66 | 2 |
Pruritus, Urinary tract infection, Eczema, |
||||
DUPILUMAB, |
||||
| 44 | 26946465 |
US |
2 | |
Urinary tract infection, |
||||
ABALOPARATIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, FLUTICASONE FUROATE, COLCHICINE, DICYCLOMINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, LINACLOTIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, SIMVASTATIN, TOPIRAMATE, |
||||
| 45 | 26946548 |
US |
68 | 2 |
Urinary tract infection, Vomiting, Diarrhoea, |
||||
ABALOPARATIDE, |
||||
| 46 | 26946736 |
US |
52 | 1 |
Back pain, Urinary tract infection, |
||||
SPARSENTAN, |
||||
| 47 | 26946752 |
US |
75 | 2 |
Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 48 | 26947065 |
US |
2 | |
Urinary tract infection, Myalgia, Dysstasia, Dizziness, Arthralgia, Insomnia, |
||||
ABALOPARATIDE, |
||||
| 49 | 26947093 |
US |
71 | 2 |
Urinary tract infection, |
||||
ABALOPARATIDE, AMLODIPINE BESYLATE, BACLOFEN, CELECOXIB, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, DULOXETINE HYDROCHLORIDE, DULOXETINE, FAMOTIDINE, GENTAMICIN SULFATE, LINACLOTIDE, LOSARTAN POTASSIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, TRAZODONE HYDROCHLORIDE, VITAMIN C, |
||||
| 50 | 26947121 |
US |
73 | 1 |
Death, Drug ineffective, Urinary tract infection, |
||||
TIOPRONIN, CARBIDOPA AND LEVODOPA, PRAMIPEXOLE, |
||||
| 51 | 26947433 |
US |
2 | |
Urinary tract infection, |
||||
ABALOPARATIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CALCIUM, ERGOCALCIFEROL, VITAMIN C, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMLODIPINE BESYLATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCITONIN SALMON, |
||||
| 52 | 26947493 |
US |
66 | 2 |
Surgery, Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 53 | 26947811 |
US |
2 | |
Urinary tract infection, Deafness, Asthenia, Diarrhoea, |
||||
RAVULIZUMAB, |
||||
| 54 | 26947840 |
US |
58 | 2 |
Urinary tract infection, Feeling abnormal, Nephrolithiasis, Headache, Injection site bruising, Back pain, Drug hypersensitivity, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 55 | 26948122 |
US |
2 | |
Urinary tract infection, Feeling abnormal, Headache, Dizziness, Palpitations, |
||||
ABALOPARATIDE, CALCIUM, FAMOTIDINE, FLUTICASONE PROPIONATE, LISINOPRIL, ROSUVASTATIN, |
||||
| 56 | 26948166 |
US |
77 | 2 |
Spinal pain, Muscle strain, Urinary tract infection, Balance disorder, Headache, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 57 | 26951850 |
70 | 1 | |
Urinary tract infection, Pleural effusion, Abdominal distension, Nonspecific reaction, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, FAMCICLOVIR, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, ROSUVASTATIN, |
||||
| 58 | 26934073 |
TR |
72 | 2 |
Urinary tract infection, |
||||
| 59 | 26934319 |
JP |
59 | 1 |
Urinary bladder atrophy, Renal transplant, Benign prostatic hyperplasia, Urinary tract infection, |
||||
DARBEPOETIN ALFA, AMLODIPINE, SPIRONOLACTONE, |
||||
| 60 | 26934366 |
AR |
62 | 2 |
Hepatic cirrhosis, Decreased immune responsiveness, Off label use, Urinary tract infection, Viral infection, Asthenia, Diarrhoea, |
||||
PANITUMUMAB, |
||||
| 61 | 26934451 |
84 | 1 | |
Urinary tract infection, Bradycardia, Blood pressure increased, Confusional state, |
||||
| 62 | 26934693 |
EU |
64 | 2 |
Gastrointestinal stromal tumour, Rash, Hypercholesterolaemia, Cystitis, Arteriosclerosis, Pain, Hyperlipidaemia, High density lipoprotein decreased, Fungal oesophagitis, Osteoarthritis, Urinary tract infection, Ligament rupture, Malaise, Haemorrhoids, Dizziness, Urinary incontinence, Nausea, Chest discomfort, Obstructive sleep apnoea syndrome, Dysuria, Arthralgia, Renal artery stenosis, Diabetes mellitus, Oedema peripheral, Snoring, Dysphagia, White blood cells urine positive, Wheezing, Insomnia, Hyperhomocysteinaemia, Tenosynovitis, Stress, Dyspepsia, Muscle spasticity, Scoliosis, Anxiety, Chest pain, Hiatus hernia, Influenza, Hypertensive crisis, Cholelithiasis, Pyrexia, Dyspnoea, Epicondylitis, Headache, Polyp, Ill-defined disorder, Cough, Trigger finger, Scar, Back pain, Nasopharyngitis, Oropharyngeal pain, Bradycardia, Blood calcium decreased, Eczema, Asthma, Limb discomfort, Drug hypersensitivity, Diastolic dysfunction, Spinal osteoarthritis, Arteriosclerosis coronary artery, Peripheral swelling, Paraesthesia, Acne, Gastrooesophageal reflux disease, Chronic gastritis, Throat irritation, Supraventricular extrasystoles, Torticollis, Abdominal distension, Tricuspid valve incompetence, Urine odour abnormal, Pain in extremity, |
||||
VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, AMLODIPINE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, VALSARTAN, VALSARTAN ORAL, DICLOFENAC, DICLOFENAC SODIUM, CANDESARTAN, HYDROCHLOROTHIAZIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SCOPOLAMINE, RAMIPRIL, TORSEMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, INDAPAMIDE, NITROGLYCERIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, INDAPAMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INDAPAMIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, PANTOPRAZOLE, PANTOPRAZOLE, DIAZEPAM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AMLODIPINE BESYLATE, CANDESARTAN, AMLODIPINE BESYLATE, |
||||
| 63 | 26934700 |
JP |
8 | 1 |
Hypotonic urinary bladder, Interstitial lung disease, Immune-mediated hypothyroidism, Benign prostatic hyperplasia, Urinary tract infection, Therapy partial responder, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 64 | 26934751 |
US |
1 | |
Urinary tract infection, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 65 | 26934766 |
CA |
34 | 2 |
Respiratory distress, Headache, Sputum discoloured, Herpes zoster, Cough, Pneumonitis, Urinary tract infection, Drug ineffective, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CLARITHROMYCIN, CLARITHROMYCIN, MONTELUKAST SODIUM, MONTELUKAST, ALBUTEROL SULFATE, PREGABALIN, OMALIZUMAB, ACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 66 | 26934912 |
US |
45 | 2 |
Urinary tract infection, Infection, |
||||
UPADACITINIB, |
||||
| 67 | 26935050 |
NZ |
2 | |
Urinary tract infection, |
||||
DAPAGLIFLOZIN, |
||||
| 68 | 26935056 |
BR |
2 | |
Skull fracture, Haemorrhoids, Carcinoembryonic antigen increased, Liver injury, Metastasis, Metastases to bone, Metastases to liver, Metastases to spine, Metastases to thorax, Metastases to thyroid, Breast cancer metastatic, Metastases to liver, Haemorrhage, Skin fissures, Face injury, Dry throat, Dry skin, Rectocele, Nasal dryness, Vulvovaginal dryness, Skin exfoliation, Nasal discomfort, Contusion, Vascular rupture, Clavicle fracture, Panic attack, Blood oestrogen decreased, Skin disorder, Skin atrophy, Pain, Injury, Bone neoplasm, Limb injury, Peripheral swelling, Skin discolouration, Hypokinesia, Movement disorder, Limb discomfort, Muscular weakness, Lymphadenopathy, Stress, Erythema, Feeling abnormal, Gastrooesophageal reflux disease, Gait disturbance, Quality of life decreased, Rhinitis, Fatigue, Bone pain, Abdominal pain upper, PIK3CA-activated mutation, Hepatic mass, Nodule, Brain fog, Weight decreased, Insomnia, Greater trochanteric pain syndrome, Dry eye, Urinary tract infection, Arthralgia, Rash macular, Pain in extremity, Epistaxis, Alopecia, Hypersensitivity, Haematoma, Pruritus, Erythema, Tumour marker increased, Injection site swelling, Drug intolerance, Dizziness, Vomiting, Head discomfort, Malaise, Constipation, Polyp, Retching, Nausea, Dehydration, Sinusitis, Eating disorder, Thermal burn, Skin lesion, Hiatus hernia, Sensory loss, Drug ineffective, Needle issue, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PANTOPRAZOLE, ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ALPELISIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CLONAZEPAM, EXEMESTANE, |
||||
| 69 | 26935084 |
US |
1 | |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, ENTACAPONE, CARBIDOPA AND LEVODOPA, FINASTERIDE, LISINOPRIL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ROPINIROLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, IRON, VITAMIN C, |
||||
| 70 | 26935581 |
US |
3 | 2 |
Urinary tract infection, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 71 | 26935982 |
US |
86 | 2 |
Urinary tract infection, Dysuria, Pollakiuria, Urine flow decreased, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 72 | 26936694 |
US |
67 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 73 | 26936894 |
US |
77 | 2 |
Urinary tract infection, |
||||
LENALIDOMIDE, |
||||
| 74 | 26937365 |
US |
77 | 1 |
Urinary tract infection, |
||||
RELUGOLIX, RELUGOLIX, CEPHALEXIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, GLIPIZIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 75 | 26937374 |
CA |
2 | |
Nephrolithiasis, Uterine stenosis, Urinary tract infection, Glomerular filtration rate decreased, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, MONTELUKAST, PRAZOSIN HYDROCHLORIDE, TOLTERODINE TARTRATE, TOLTERODINE, TOPIRAMATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALLOPURINOL, BUPROPION, |
||||
| 76 | 26937721 |
MX |
31 | 2 |
Leukopenia, Lymphopenia, Urinary tract infection, Off label use, |
||||
FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, |
||||
| 77 | 26937848 |
57 | 2 | |
Urinary tract infection, |
||||
| 78 | 26937851 |
US |
53 | 2 |
Joint stiffness, Pain in extremity, Urinary tract infection, |
||||
ASFOTASE ALFA, |
||||
| 79 | 26938291 |
2 | ||
Urinary tract infection, |
||||
MOMELOTINIB, |
||||
| 80 | 26938352 |
EU |
38 | 2 |
Breast abscess, Confusional state, Erythema, Bacteriuria, Bradycardia, Urinary tract infection, Urinary tract infection, Fall, Irritability, Amenorrhoea, Burning sensation, Disturbance in attention, Psychomotor retardation, Aphasia, Groin pain, Drug abuse, Decreased appetite, Weight decreased, Traumatic haematoma, |
||||
ALEMTUZUMAB, METHYLPREDNISOLONE, ACYCLOVIR, VALPROATE SODIUM, ALPRAZOLAM, PREGABALIN, ALPRAZOLAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 81 | 26938484 |
81 | 1 | |
Urinary tract infection, |
||||
VENETOCLAX, |
||||
| 82 | 26938661 |
GB |
37 | 2 |
Weight decreased, Malnutrition, Dehydration, Blood pressure decreased, Blood glucose decreased, Decreased appetite, Urinary tract infection, Eating disorder, Renal injury, Cholecystitis, Alopecia, Body dysmorphic disorder, Drug abuse, Impaired gastric emptying, Off label use, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 83 | 26939308 |
US |
62 | 2 |
Dry mouth, Injection site pain, Headache, Urinary tract infection, Liquid product physical issue, |
||||
ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CYCLOBENZAPRINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUCONAZOLE, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPYLTHIOURACIL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, |
||||
| 84 | 26939333 |
US |
2 | |
Abdominal discomfort, Headache, Palpitations, Product dose omission issue, Product use issue, Urinary tract infection, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, FISH OIL, ERGOCALCIFEROL, |
||||
| 85 | 26939353 |
US |
84 | 2 |
Blood urine present, Urinary tract infection, Diarrhoea, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 86 | 26939580 |
US |
2 | |
Spinal fusion surgery, Urinary tract infection, Procedural pain, Hypoaesthesia, Burning sensation, Gait disturbance, Joint instability, Paraesthesia, Dyspepsia, Neuralgia, Back pain, Headache, Arthralgia, Fatigue, Off label use, |
||||
ABALOPARATIDE, |
||||
| 87 | 26939588 |
US |
2 | |
Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 88 | 26939615 |
CA |
47 | 1 |
Asthenia, Urinary tract infection, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 89 | 26939657 |
US |
2 | |
Back pain, Urinary tract infection, |
||||
ABALOPARATIDE, |
||||
| 90 | 26939743 |
US |
2 | |
Abdominal tenderness, Vitamin D deficiency, Urinary tract infection, External ear pain, Dysuria, Headache, |
||||
ABALOPARATIDE, ABALOPARATIDE, GABAPENTIN, MAGNESIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 91 | 26943145 |
|||
Calculus bladder, Urinary tract infection, |
||||
TEZEPELUMAB-EKKO, |
||||
| 92 | 26943429 |
70 | 2 | |
Hereditary angioedema, Urinary tract infection, |
||||
ICATIBANT, |
||||
| 93 | 26931308 |
US |
2 | |
Enteritis infectious, Urinary tract infection, Illness, Dehydration, |
||||
TIRZEPATIDE, |
||||
| 94 | 26931528 |
US |
70 | 2 |
Tremor, Muscular weakness, Urinary tract infection, Fatigue, Visual impairment, Vision blurred, |
||||
NIPOCALIMAB-AAHU, |
||||
| 95 | 26931612 |
CN |
82 | 1 |
Hepatic function abnormal, Jaundice, Respiratory failure, Altered state of consciousness, Acidosis, Hepatic function abnormal, Jaundice, Urinary tract infection, Pain in extremity, Anaemia, Urinary tract infection, Constipation, Urinary tract infection, Hypoalbuminaemia, |
||||
SOTORASIB, |
||||
| 96 | 26931667 |
EU |
||
Septic shock, Off label use, Metabolic disorder, Fatigue, Mental disorder, Atrial fibrillation, Injury, Neutropenia, Urinary tract infection, Angiopathy, COVID-19, Benign neoplasm, Infusion related reaction, Renal disorder, COVID-19 pneumonia, Dyspnoea, Poisoning, Procedural complication, Nausea, Vision blurred, Neoplasm malignant, Neoplasm, Dry eye, Anaemia, Oedema peripheral, Arthralgia, Skin disorder, Hypertension, Cyst, Urinary tract disorder, Eye irritation, Pneumonia, Malnutrition, Diarrhoea, Cough, Infestation, Polyp, General symptom, Cardiac disorder, Spinal disorder, Investigation abnormal, Gastrointestinal disorder, Nervous system disorder, Respiratory disorder, Musculoskeletal disorder, Adverse event, Lymphatic disorder, Eye disorder, Administration site reaction, Mediastinal disorder, Blood disorder, Infection, Connective tissue disorder, |
||||
IBRUTINIB, RITUXIMAB, |
||||
| 97 | 26931669 |
TW |
2 | |
Stevens-Johnson syndrome, Urinary tract infection, Liver function test abnormal, Pyrexia, Eye operation, Product use issue, |
||||
BRIVARACETAM, LACOSAMIDE, LAMOTRIGINE, LAMOTRIGINE, |
||||
| 98 | 26931723 |
US |
2 | |
Urinary tract infection, Illness, Pyrexia, Blood pressure fluctuation, Chills, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 99 | 26931803 |
US |
80 | |
Respiration abnormal, White blood cell count decreased, Urinary tract infection, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 100 | 26931815 |
US |
74 | 2 |
Lower limb fracture, Urinary tract infection, Product dose omission issue, |
||||
OLAPARIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30